FDPS Activators
FDPS activators encompass an array of chemicals that indirectly influence the enzyme's activity by affecting the mevalonate pathway, of which FDPS is a pivotal part. Many of these chemicals, such as Mevalonic acid, Geranyl pyrophosphate, and Isopentenyl pyrophosphate, are intermediates within the mevalonate pathway itself. Their increased levels can naturally stimulate upstream enzymes, including FDPS, to restore balance. Similarly, crucial substrates and cofactors for the pathway, like Acetyl-CoA, NADPH, Magnesium, and Zinc, can potentially amplify the pathway's progression, subsequently enhancing FDPS activity.
Other chemicals, such as Lovastatin and Cholesterol, have more complex interactions with the mevalonate pathway. Lovastatin, for instance, primarily inhibits HMG-CoA reductase, another enzyme in the pathway. However, the body may respond by boosting the activity of other enzymes, including FDPS, to compensate. Cholesterol, being a product of the pathway, can regulate its own synthesis. If cholesterol levels drop, the body might upregulate the mevalonate pathway, indirectly stimulating FDPS. Lastly, solvents like DMSO known to affect cellular processes and membrane dynamics, can have indirect impacts on the pathway, potentially influencing FDPS activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetyl coenzyme A trisodium salt | 102029-73-2 | sc-210745 sc-210745A sc-210745B | 1 mg 5 mg 1 g | $47.00 $92.00 $5826.00 | 3 | |
A primary substrate for the mevalonate pathway. Abundant acetyl-CoA can push the pathway forward, indirectly activating FDPS. | ||||||
NADPH tetrasodium salt | 2646-71-1 | sc-202725 sc-202725A sc-202725B sc-202725C | 25 mg 50 mg 250 mg 1 g | $47.00 $84.00 $286.00 $754.00 | 11 | |
Essential co-factor for HMG-CoA reductase, the key regulatory enzyme in the mevalonate pathway. An increase can drive the pathway and indirectly activate FDPS. | ||||||
Squalene | 111-02-4 | sc-281155 sc-281155A sc-281155B | 10 ml 100 ml 500 ml | $49.00 $92.00 $215.00 | 1 | |
A downstream product in the pathway. Increased squalene might indicate a need for more precursors, potentially promoting FDPS activity. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Though primarily an inhibitor of HMG-CoA reductase, its presence can lead to a compensatory activation of other enzymes in the pathway, including FDPS. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $27.00 $2809.00 $129.00 $210.00 $583.00 $88.00 | 11 | |
A product of the mevalonate pathway. Reduced levels can upregulate the entire pathway, potentially activating FDPS. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Another cofactor for FDPS. Enhanced zinc levels can potentially promote FDPS activity. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
A solvent that can change membrane fluidity and might indirectly impact enzymes involved in cholesterol biosynthesis, including FDPS. | ||||||